Your browser doesn't support javascript.
loading
BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylation.
Sartori, Maxime; Mendes, Tiago; Desai, Shruti; Lasorsa, Alessia; Herledan, Adrien; Malmanche, Nicolas; Mäkinen, Petra; Marttinen, Mikael; Malki, Idir; Chapuis, Julien; Flaig, Amandine; Vreulx, Anaïs-Camille; Ciancia, Marion; Amouyel, Philippe; Leroux, Florence; Déprez, Benoit; Cantrelle, François-Xavier; Maréchal, Damien; Pradier, Laurent; Hiltunen, Mikko; Landrieu, Isabelle; Kilinc, Devrim; Herault, Yann; Laporte, Jocelyn; Lambert, Jean-Charles.
Afiliação
  • Sartori M; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 1 rue Laurent Fries, 67404, Illkirch, France.
  • Mendes T; INSERM U1258, Illkirch, France.
  • Desai S; CNRS UMR7104, Illkirch, France.
  • Lasorsa A; Strasbourg University, Illkirch, France.
  • Herledan A; INSERM U1167, RID-AGE: Risk Factors and Molecular Determinants of Aging-Related Diseases, Institut Pasteur de Lille, 1 rue du Pr. Calmette, 59019, Lille, France.
  • Malmanche N; Institut Pasteur de Lille, Lille, France.
  • Mäkinen P; University of Lille, DISTALZ Laboratory of Excellence (LabEx), Lille, France.
  • Marttinen M; SANOFI Neuroscience Therapeutic Area, Chilly-Mazarin, France.
  • Malki I; INSERM U1167, RID-AGE: Risk Factors and Molecular Determinants of Aging-Related Diseases, Institut Pasteur de Lille, 1 rue du Pr. Calmette, 59019, Lille, France.
  • Chapuis J; Institut Pasteur de Lille, Lille, France.
  • Flaig A; University of Lille, DISTALZ Laboratory of Excellence (LabEx), Lille, France.
  • Vreulx AC; University of Lille, DISTALZ Laboratory of Excellence (LabEx), Lille, France.
  • Ciancia M; CNRS UMR8576, Lille, France.
  • Amouyel P; Institut Pasteur de Lille, Lille, France.
  • Leroux F; University of Lille, EGID, Lille, France.
  • Déprez B; INSERM U1177, Drugs and Molecules for Living Systems, Lille, France.
  • Cantrelle FX; INSERM U1167, RID-AGE: Risk Factors and Molecular Determinants of Aging-Related Diseases, Institut Pasteur de Lille, 1 rue du Pr. Calmette, 59019, Lille, France.
  • Maréchal D; Institut Pasteur de Lille, Lille, France.
  • Pradier L; University of Lille, DISTALZ Laboratory of Excellence (LabEx), Lille, France.
  • Hiltunen M; Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
  • Landrieu I; Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
  • Kilinc D; University of Lille, DISTALZ Laboratory of Excellence (LabEx), Lille, France.
  • Herault Y; CNRS UMR8576, Lille, France.
  • Laporte J; INSERM U1167, RID-AGE: Risk Factors and Molecular Determinants of Aging-Related Diseases, Institut Pasteur de Lille, 1 rue du Pr. Calmette, 59019, Lille, France.
  • Lambert JC; Institut Pasteur de Lille, Lille, France.
Acta Neuropathol ; 138(4): 631-652, 2019 10.
Article em En | MEDLINE | ID: mdl-31065832
ABSTRACT
The bridging integrator 1 gene (BIN1) is a major genetic risk factor for Alzheimer's disease (AD). In this report, we investigated how BIN1-dependent pathophysiological processes might be associated with Tau. We first generated a cohort of control and transgenic mice either overexpressing human MAPT (TgMAPT) or both human MAPT and BIN1 (TgMAPT;TgBIN1), which we followed-up from 3 to 15 months. In TgMAPT;TgBIN1 mice short-term memory deficits appeared earlier than in TgMAPT mice; however-unlike TgMAPT mice-TgMAPT;TgBIN1 mice did not exhibit any long-term or spatial memory deficits for at least 15 months. After killing the cohort at 18 months, immunohistochemistry revealed that BIN1 overexpression prevents both Tau mislocalization and somatic inclusion in the hippocampus, where an increase in BIN1-Tau interaction was also observed. We then sought mechanisms controlling the BIN1-Tau interaction. We developed a high-content screening approach to characterize modulators of the BIN1-Tau interaction in an agnostic way (1,126 compounds targeting multiple pathways), and we identified-among others-an inhibitor of calcineurin, a Ser/Thr phosphatase. We determined that calcineurin dephosphorylates BIN1 on a cyclin-dependent kinase phosphorylation site at T348, promoting the open conformation of the neuronal BIN1 isoform. Phosphorylation of this site increases the availability of the BIN1 SH3 domain for Tau interaction, as demonstrated by nuclear magnetic resonance experiments and in primary neurons. Finally, we observed that although the levels of the neuronal BIN1 isoform were unchanged in AD brains, phospho-BIN1(T348)BIN1 ratio was increased, suggesting a compensatory mechanism. In conclusion, our data support the idea that BIN1 modulates the AD risk through an intricate regulation of its interaction with Tau. Alteration in BIN1 expression or activity may disrupt this regulatory balance with Tau and have direct effects on learning and memory.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas tau / Tauopatias / Proteínas Supressoras de Tumor / Proteínas Adaptadoras de Transdução de Sinal / Memória de Longo Prazo / Transtornos da Memória / Proteínas do Tecido Nervoso Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas tau / Tauopatias / Proteínas Supressoras de Tumor / Proteínas Adaptadoras de Transdução de Sinal / Memória de Longo Prazo / Transtornos da Memória / Proteínas do Tecido Nervoso Idioma: En Ano de publicação: 2019 Tipo de documento: Article